Bluebird Bio Sharply Higher After Mixed Q3 Report

Bluebird bio Inc BLUE shares are trading higher by $15.30 or 11 percent at $154.40 in Wednesday's session. Before the open, the company reported a third-quarter EPS miss of 2 cents but had a revenue beat of over $700,000.

After a much higher open, it had a brief retreat to $143.95, which is more than $1 above the top of Tuesday's range ($142.75), and then continued its move higher. The powerful rally took the issue all the way to $161.82, before falling back in the $150.00 handle. That marks the first the time the issue has traded over $160.00 since Aug. 6, 2015, when it peaked at $168.03.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: TechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!